Τhe methylation of SHOX2 promoter in primary tissues is associated with unfavorable prognosis in early stage NSCLC patients and the methylation of SLFN11 and APC promoter in cfDNA is associated with decreased DFI. The gene discussed is SLFN11; the disease is non-small cell lung carcinoma.